PMLiVEcom Profile Banner
Pharmaceutical Market Europe Profile
Pharmaceutical Market Europe

@PMLiVEcom

Followers
16K
Following
358
Media
634
Statuses
21K

News & analysis of healthcare, pharma and biotech. Magazines, directories, profiles, jobs & awards.

Surrey, UK
Joined June 2009
Don't wanna be here? Send us removal request.
@PMLiVEcom
Pharmaceutical Market Europe
13 hours
NICE recommends ALK’s immunotherapy to target underlying cause of hay fever
Tweet card summary image
pmlive.com
An estimated 26,800 people in England with moderate-to-severe cases could benefit from Itulazax
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
13 hours
Roche’s Itovebi granted EC approval to treat advanced breast cancer patients
Tweet card summary image
pmlive.com
Hormone receptor-positive breast cancer accounts for around 70% of all breast cancer cases
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
14 hours
AstraZeneca unveils plans to boost US footprint with $50bn investment
Tweet card summary image
pmlive.com
The funds will go towards establishing a multi-billion dollar drug substance facility in Virginia
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
Eli Lilly/Almirall’s Ebglyss shows promise in atopic dermatitis patients with darker skin tones
Tweet card summary image
pmlive.com
The inflammatory skin condition occurs in approximately 7.3% of adults in the US
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
Biogen to boost US manufacturing footprint with $2bn North Carolina investment
Tweet card summary image
pmlive.com
The commitment is aimed at advancing the company's late-stage clinical pipeline
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
Sanofi to expand respiratory vaccines pipeline with $1.6bn Vicebio acquisition
Tweet card summary image
pmlive.com
The deal includes an early-stage combination vaccine candidate for RSV and hMPV
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
In the latest issue of PME, Karen Harris explores how current market challenges are redefining the biotech landscape. Check out her article below: #Biotech #DrugFunding #Pharma #Health #PME.
Tweet card summary image
pmlive.com
Short-term uncertainty is slowing investment activity, but the long-term outlook remains strong
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
2 days
US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities
Tweet card summary image
pmlive.com
Download the first edition of the Petauri ‘US Payer Panel Insights Survey: Evolving Evidence Landscape and Priorities’ report
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
EC approves SpringWorks Therapeutics’ Ezmekly to treat rare genetic disorder NF1
Tweet card summary image
pmlive.com
Neurofibromatosis type 1 affects an estimated 135,000 people in the EU
0
1
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
AstraZeneca shares late-stage results for Tagrisso combination in lung cancer
Tweet card summary image
pmlive.com
An estimated 2.4 million people globally are diagnosed with lung cancer each year
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
In Uptake's latest column, Jo Lopez explores how integrating AI across the commercialisation process can drive better outcomes: #HealthcareComms #HealthcareMarketing #AIinPharma #DrugLaunch #Pharma #Health #PME.
Tweet card summary image
pmlive.com
How integrating AI across the commercialisation process can drive better outcomes
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
3 days
LEO Pharma gains access to Boehringer’s skin disease drug for €90m upfront
Tweet card summary image
pmlive.com
Spevigo is already approved in over 40 countries to treat generalised pustular psoriasis
0
1
0
@PMLiVEcom
Pharmaceutical Market Europe
6 days
Alnylam’s Amvuttra approved by MHRA to treat rare heart disease ATTR-CM
Tweet card summary image
pmlive.com
The drug has been authorised to treat both wild-type and hereditary forms of the disease
0
1
0
@PMLiVEcom
Pharmaceutical Market Europe
6 days
NICE recommends BeOne’s Brukinsa to treat mantle cell lymphoma on NHS
pmlive.com
Approximately 600 people are affected by the form of non-Hodgkin lymphoma every year in the UK
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
6 days
Johnson & Johnson’s TAR-200 granted FDA priority review to treat bladder cancer
Tweet card summary image
pmlive.com
An estimated 84,870 people will be diagnosed with bladder cancer in the US this year
0
0
0
@PMLiVEcom
Pharmaceutical Market Europe
6 days
Check out Lindy Crimmins' article in the latest issue of PME on the substantial burden of sepsis and the impact of antibiotic resistance: #AntibioticResistance #AMR #Sepsis #Pharma #Health #PME.
Tweet card summary image
pmlive.com
A WHO report emphasises the serious global impact of antimicrobial resistance, which exacerbates the substantial burden of sepsis on patients, HCPs and health systems
0
0
0